(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.67%) $83.29
(-1.16%) $1.619
(-0.02%) $2 346.80
(-0.04%) $27.53
(0.21%) $924.00
(-0.09%) $0.934
(-0.03%) $11.02
(-0.12%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail...
Stats | |
---|---|
Šios dienos apimtis | 28 650.00 |
Vidutinė apimtis | 51 860.00 |
Rinkos kapitalizacija | 608.82M |
Last Dividend | €1.100 ( 2023-04-20 ) |
Next Dividend | €0 ( N/A ) |
P/E | 15.93 |
ATR14 | €0 (0.00%) |
Uniphar Group Plc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Uniphar Group Plc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | €2.55B |
Bruto pelnas: | €389.98M (15.28 %) |
EPS: | €0.160 |
FY | 2023 |
Pajamos: | €2.55B |
Bruto pelnas: | €389.98M (15.28 %) |
EPS: | €0.160 |
FY | 2022 |
Pajamos: | €2.07B |
Bruto pelnas: | €306.74M (14.81 %) |
EPS: | €0.170 |
FY | 2021 |
Pajamos: | €1.94B |
Bruto pelnas: | €274.50M (14.13 %) |
EPS: | €0.180 |
Financial Reports:
No articles found.
Uniphar Group Plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.610 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.100 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.730 | 2020-04-30 |
Last Dividend | €1.100 | 2023-04-20 |
Next Dividend | €0 | N/A |
Payout Date | 2023-05-16 | |
Next Payout Date | N/A | |
# dividends | 7 | -- |
Total Paid Out | €5.60 | -- |
Avg. Dividend % Per Year | 0.34% | -- |
Score | 2.82 | -- |
Div. Sustainability Score | 9.35 | |
Div.Growth Potential Score | 4.75 | |
Div. Directional Score | 7.05 | -- |
Year | Amount | Yield |
---|---|---|
2020 | €0.730 | 0.60% |
2021 | €2.06 | 0.84% |
2022 | €1.710 | 0.42% |
2023 | €1.100 | 0.40% |
2024 | €0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RST.L | Dividend Junior | 2023-09-21 | Annually | 13 | 0.98% | |
HIK.L | Dividend Knight | 2023-08-10 | Semi-Annually | 19 | 1.60% | |
AZN.L | Ex Dividend Knight | 2023-08-10 | Semi-Annually | 32 | 1.07% | |
VIC.L | Dividend Knight | 2023-06-08 | Semi-Annually | 2 | 0.88% | |
MRO.L | Dividend Junior | 2023-09-14 | Semi-Annually | 19 | 2.42% | |
DNA3.L | Dividend Royal | 2023-07-20 | Quarterly | 12 | 10.69% | |
SHOE.L | Dividend Knight | 2023-07-13 | Annually | 10 | 2.57% | |
III.L | Dividend King | 2023-06-22 | Semi-Annually | 31 | 1.93% | |
BOWL.L | Dividend Knight | 2023-06-08 | Annually | 8 | 1.03% | |
OOA.L | Dividend Knight | 2023-07-27 | Semi-Annually | 17 | 2.87% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0205 | 1.500 | 9.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0503 | 1.200 | 8.32 | 9.99 | [0 - 0.3] |
returnOnEquityTTM | 0.204 | 1.500 | 8.85 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0869 | -1.000 | 9.13 | -9.13 | [0 - 1] |
currentRatioTTM | 0.885 | 0.800 | -0.575 | -0.460 | [1 - 3] |
quickRatioTTM | 0.503 | 0.800 | -1.749 | -1.399 | [0.8 - 2.5] |
cashRatioTTM | 0.149 | 1.500 | -0.282 | -0.423 | [0.2 - 2] |
debtRatioTTM | 0.296 | -1.500 | 5.06 | -7.59 | [0 - 0.6] |
interestCoverageTTM | 4.06 | 1.000 | 9.61 | 9.61 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.401 | 2.00 | 9.87 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.272 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.148 | -1.500 | 5.41 | -8.11 | [0 - 2.5] |
grossProfitMarginTTM | 0.152 | 1.000 | -0.807 | -0.807 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0320 | 1.000 | -1.360 | -1.360 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.287 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 2.45 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 9.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.39 | 1.000 | 9.15 | 0 | [1 - 100] |
returnOnEquityTTM | 0.204 | 2.50 | 9.26 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.272 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.821 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.401 | 2.00 | 9.87 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0869 | 1.500 | 9.13 | -9.13 | [0 - 1] |
pegRatioTTM | -7.96 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0347 | 1.000 | -1.634 | 0 | [0.1 - 0.5] |
Total Score | 4.75 |
Uniphar Group Plc
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.